IDEXX LABORATORIES INC /DE (IDXX) › Cash & EquivalentsIDEXX LABORATORIES INC /DE (IDXX) — Cash & EquivalentsAnnual figures by fiscal year, from SEC filings.2007: $60.36M2008: $78.87M2009: $106.73M2010: $156.91M2011: $183.90M2012: $223.99M2013: $279.06M2014: $322.54M2015: $128.99M2016: $154.90M2017: $187.68M2018: $123.79M2019: $90.33M2020: $383.93M2021: $144.45M2022: $112.55M2023: $453.93M2024: $288.27M2025: $180.07M$180.07M2007Cash & Equivalents (USD)2025Fiscal YearCash & EquivalentsChange YoY2025$180.07M-37.5%2024$288.27M-36.5%2023$453.93M+303.3%2022$112.55M-22.1%2021$144.45M-62.4%2020$383.93M+325.0%2019$90.33M-27.0%2018$123.79M-34.0%2017$187.68M+21.2%2016$154.90M+20.1%2015$128.99M-60.0%2014$322.54M+15.6%2013$279.06M+24.6%2012$223.99M+21.8%2011$183.90M+17.2%2010$156.91M+47.0%2009$106.73M+35.3%2008$78.87M+30.7%2007$60.36M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share